QS Investors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,090
| Closed | -$316K | – | 1228 |
|
|
2020
Q4 | $316K | Hold |
5,090
| – | – | ﹤0.01% | 971 |
|
|
2020
Q3 | $303K | Sell |
5,090
-16,334
| -76% | -$972K | ﹤0.01% | 916 |
|
|
2020
Q2 | $1.5M | Hold |
21,424
| – | – | 0.02% | 597 |
|
|
2020
Q1 | $972K | Buy |
21,424
+120
| +0.6% | +$5.44K | 0.02% | 669 |
|
|
2019
Q4 | $1.39M | Sell |
21,304
-160
| -0.7% | -$10.5K | 0.01% | 692 |
|
|
2019
Q3 | $1.33M | Hold |
21,464
| – | – | 0.01% | 694 |
|
|
2019
Q2 | $1.53M | Sell |
21,464
-513
| -2% | -$36.5K | 0.02% | 673 |
|
|
2019
Q1 | $1.72M | Buy |
21,977
+21,171
| +2,627% | +$1.66M | 0.02% | 664 |
|
|
2018
Q4 | $69K | Hold |
806
| – | – | ﹤0.01% | 1407 |
|
|
2018
Q3 | $138K | Hold |
806
| – | – | ﹤0.01% | 1310 |
|
|
2018
Q2 | $104K | Hold |
806
| – | – | ﹤0.01% | 1397 |
|
|
2018
Q1 | $83K | Hold |
806
| – | – | ﹤0.01% | 1406 |
|
|
2017
Q4 | $69K | Hold |
806
| – | – | ﹤0.01% | 1430 |
|
|
2017
Q3 | $68K | Hold |
806
| – | – | ﹤0.01% | 1459 |
|
|
2017
Q2 | $61K | Hold |
806
| – | – | ﹤0.01% | 1471 |
|
|
2017
Q1 | $53K | Buy |
806
+801
| +16,020% | +$52.7K | ﹤0.01% | 1495 |
|
|
2016
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1656 |
|
|
2016
Q3 | $1K | Buy |
5
+2
| +67% | +$400 | ﹤0.01% | 1641 |
|
|
2016
Q2 | $1K | Sell |
3
-5
| -63% | -$1.67K | ﹤0.01% | 1680 |
|
|
2016
Q1 | $1K | Buy |
8
+5
| +167% | +$625 | ﹤0.01% | 1675 |
|
|
2015
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 1701 |
|